Annual Retained Earnings
-$1.96 B
-$572.84 M-41.31%
December 31, 2022
Summary
- As of February 23, 2025, SRNE annual retained earnings is -$1.96 billion, with the most recent change of -$572.84 million (-41.31%) on December 31, 2022.
- During the last 3 years, SRNE annual retained earnings has fallen by -$1.30 billion (-196.97%).
- SRNE annual retained earnings is now -1663267.57% below its all-time high of -$117.80 thousand, reached on December 31, 2008.
Performance
SRNE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$2.19 B
-$95.21 M-4.54%
June 30, 2023
Summary
- As of February 23, 2025, SRNE quarterly retained earnings is -$2.19 billion, with the most recent change of -$95.21 million (-4.54%) on June 30, 2023.
- Over the past year, SRNE quarterly retained earnings has dropped by -$95.21 million (-4.54%).
- SRNE quarterly retained earnings is now -1862612.22% below its all-time high of -$117.80 thousand, reached on December 31, 2008.
Performance
SRNE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
SRNE Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.3% | -4.5% |
| 3 y3 years | -197.0% | -4.5% |
| 5 y5 years | -1086.7% | -4.5% |
SRNE Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -41.3% | at low | -58.3% | at low |
| 5 y | 5-year | -197.0% | at low | -232.6% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Sorrento Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$2.19 B(+4.5%) |
| Mar 2023 | - | -$2.10 B(+7.1%) |
| Dec 2022 | -$1.96 B(+41.3%) | -$1.96 B(+12.9%) |
| Sep 2022 | - | -$1.74 B(+5.4%) |
| Jun 2022 | - | -$1.65 B(+15.3%) |
| Mar 2022 | - | -$1.43 B(+2.9%) |
| Dec 2021 | -$1.39 B(+44.7%) | -$1.39 B(+11.6%) |
| Sep 2021 | - | -$1.24 B(+10.7%) |
| Jun 2021 | - | -$1.12 B(+17.4%) |
| Mar 2021 | - | -$955.77 M(-0.3%) |
| Dec 2020 | -$958.28 M(+45.2%) | -$958.28 M(+8.1%) |
| Sep 2020 | - | -$886.78 M(+10.5%) |
| Jun 2020 | - | -$802.75 M(+10.7%) |
| Mar 2020 | - | -$725.01 M(+9.9%) |
| Dec 2019 | -$659.82 M(+79.4%) | -$659.82 M(+10.5%) |
| Sep 2019 | - | -$597.00 M(+12.1%) |
| Jun 2019 | - | -$532.58 M(+11.9%) |
| Mar 2019 | - | -$475.82 M(+29.4%) |
| Dec 2018 | -$367.75 M(+122.7%) | -$367.75 M(+15.7%) |
| Sep 2018 | - | -$317.97 M(+17.5%) |
| Jun 2018 | - | -$270.65 M(+37.5%) |
| Mar 2018 | - | -$196.78 M(+19.2%) |
| Dec 2017 | -$165.12 M(-5.2%) | -$165.12 M(-7.0%) |
| Sep 2017 | - | -$177.54 M(-16.1%) |
| Jun 2017 | - | -$211.50 M(+7.2%) |
| Mar 2017 | - | -$197.32 M(+13.2%) |
| Dec 2016 | -$174.25 M(+53.8%) | -$174.25 M(+7.4%) |
| Sep 2016 | - | -$162.30 M(-8.1%) |
| Jun 2016 | - | -$176.67 M(+34.1%) |
| Mar 2016 | - | -$131.72 M(+16.2%) |
| Dec 2015 | -$113.33 M(+67.9%) | -$113.33 M(+26.1%) |
| Sep 2015 | - | -$89.85 M(+1.1%) |
| Jun 2015 | - | -$88.91 M(+14.1%) |
| Mar 2015 | - | -$77.96 M(+15.5%) |
| Dec 2014 | -$67.52 M(+105.5%) | -$67.52 M(+14.4%) |
| Sep 2014 | - | -$59.01 M(+14.8%) |
| Jun 2014 | - | -$51.41 M(+19.7%) |
| Mar 2014 | - | -$42.95 M(+30.7%) |
| Dec 2013 | -$32.86 M | -$32.86 M(+52.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | -$21.57 M(+18.4%) |
| Jun 2013 | - | -$18.21 M(+35.2%) |
| Mar 2013 | - | -$13.47 M(+23.0%) |
| Dec 2012 | -$10.95 M(+79.4%) | -$10.95 M(+19.1%) |
| Sep 2012 | - | -$9.20 M(+15.6%) |
| Jun 2012 | - | -$7.95 M(+13.5%) |
| Mar 2012 | - | -$7.01 M(+14.8%) |
| Dec 2011 | -$6.11 M(+112.8%) | -$6.11 M(+14.3%) |
| Sep 2011 | - | -$5.34 M(+15.1%) |
| Jun 2011 | - | -$4.64 M(+30.6%) |
| Mar 2011 | - | -$3.55 M(+23.9%) |
| Dec 2010 | -$2.87 M(+170.6%) | -$2.87 M(+7.0%) |
| Sep 2010 | - | -$2.68 M(+19.9%) |
| Jun 2010 | - | -$2.24 M(+34.7%) |
| Mar 2010 | - | -$1.66 M(+56.6%) |
| Dec 2009 | -$1.06 M(+799.9%) | -$1.06 M(+183.3%) |
| Sep 2009 | - | -$374.20 K(-79.2%) |
| Jun 2009 | - | -$1.80 M(+4.6%) |
| Mar 2009 | - | -$1.72 M(+1361.0%) |
| Dec 2008 | -$117.80 K(-92.0%) | -$117.80 K(-92.7%) |
| Sep 2008 | - | -$1.62 M(+8.4%) |
| Jun 2008 | - | -$1.49 M(+0.4%) |
| Mar 2008 | - | -$1.49 M(+0.9%) |
| Dec 2007 | -$1.47 M(+22.5%) | -$1.47 M(+0.5%) |
| Sep 2007 | - | -$1.47 M(+0.7%) |
| Jun 2007 | - | -$1.46 M(+0.9%) |
| Mar 2007 | - | -$1.44 M(+19.9%) |
| Dec 2006 | -$1.20 M(+57.5%) | -$1.20 M(+57.5%) |
| Sep 2006 | - | -$763.90 K(0.0%) |
| Jun 2006 | - | -$763.90 K(0.0%) |
| Mar 2006 | - | -$763.90 K(0.0%) |
| Dec 2005 | -$763.90 K(-28.7%) | -$763.90 K(-28.8%) |
| Sep 2005 | - | -$1.07 M(+0.0%) |
| Jun 2005 | - | -$1.07 M(+0.0%) |
| Mar 2005 | - | -$1.07 M(+0.0%) |
| Dec 2004 | -$1.07 M(+0.1%) | -$1.07 M(+0.0%) |
| Sep 2004 | - | -$1.07 M(+0.0%) |
| Jun 2004 | - | -$1.07 M(+0.0%) |
| Mar 2004 | - | -$1.07 M |
| Dec 2003 | -$1.07 M | - |
FAQ
- What is Sorrento Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Sorrento Therapeutics?
- What is Sorrento Therapeutics annual retained earnings year-on-year change?
- What is Sorrento Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Sorrento Therapeutics?
- What is Sorrento Therapeutics quarterly retained earnings year-on-year change?
What is Sorrento Therapeutics annual retained earnings?
The current annual retained earnings of SRNE is -$1.96 B
What is the all time high annual retained earnings for Sorrento Therapeutics?
Sorrento Therapeutics all-time high annual retained earnings is -$117.80 K
What is Sorrento Therapeutics annual retained earnings year-on-year change?
Over the past year, SRNE annual retained earnings has changed by -$572.84 M (-41.31%)
What is Sorrento Therapeutics quarterly retained earnings?
The current quarterly retained earnings of SRNE is -$2.19 B
What is the all time high quarterly retained earnings for Sorrento Therapeutics?
Sorrento Therapeutics all-time high quarterly retained earnings is -$117.80 K
What is Sorrento Therapeutics quarterly retained earnings year-on-year change?
Over the past year, SRNE quarterly retained earnings has changed by -$95.21 M (-4.54%)